Differential regulation of glutamate-cysteine ligase subunit expression and increased holoenzyme formation in response to cysteine deprivation

Jeong In Lee, Joann J. Kang, Martha H. Stipanuk

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

GCL (glutamate-cysteine ligase) is a heterodimer of a GCLC (GCL catalytic subunit) that possesses all of the enzymatic activity and a GCLM (GCL modifier subunit) that alters the Ki of GCLC for GSH. We hypothesized that the expression of GCLM and the association of GCLM with GCLC were responsible for the apparent increase in GCL activity state observed in the liver of rats fed low-protein diets or in hepatocytes cultured in low-sulphur amino acid-containing medium. Therefore we conducted a series of studies using rats and a human hepatoma (HepG2/C3A) cell line to assess the role of GCLM and holoenzyme formation in the regulation of GCL activity in response to sulphur amino acid intake or availability. Increases in GCL activity in rat liver, as well as in HepG2 cells, were due to the additive effects of changes in the amount of GCLC and the kcat for GCLC. The increase in the k cat for GCLC was associated with increased holoenzyme formation, which was associated with an increase in the molar ratio of GCLM to GCLC. Furthermore, our results indicate that the GCLM level in rat liver is always limiting and that up-regulation of the GCLM level results in increased holoenzyme formation and an increase in the kcat. This is the first report demonstrating that the catalytic efficiency of rat GCL is increased by holoenzyme formation and the first demonstration of differential up-regulation of the GCL subunits in response to cysteine deprivation.

Original languageEnglish (US)
Pages (from-to)181-190
Number of pages10
JournalBiochemical Journal
Volume393
Issue number1
DOIs
StatePublished - Jan 1 2006
Externally publishedYes

Fingerprint

Glutamate-Cysteine Ligase
Holoenzymes
Cysteine
Catalytic Domain
Rats
Liver
Sulfur Amino Acids
Hep G2 Cells
Up-Regulation
Protein-Restricted Diet
Nutrition
Hepatocytes
Hepatocellular Carcinoma
Cats
Demonstrations
Cells
Availability
Cell Line

Keywords

  • Cysteine
  • Glutamate-cysteine ligase (GCL)
  • Glutathione (GSH)
  • HepG2/C3A cells
  • Holoenzyme
  • Low-protein diet

ASJC Scopus subject areas

  • Biochemistry

Cite this

Differential regulation of glutamate-cysteine ligase subunit expression and increased holoenzyme formation in response to cysteine deprivation. / Lee, Jeong In; Kang, Joann J.; Stipanuk, Martha H.

In: Biochemical Journal, Vol. 393, No. 1, 01.01.2006, p. 181-190.

Research output: Contribution to journalArticle

@article{33008ead2d74448380e9cff164d9cf28,
title = "Differential regulation of glutamate-cysteine ligase subunit expression and increased holoenzyme formation in response to cysteine deprivation",
abstract = "GCL (glutamate-cysteine ligase) is a heterodimer of a GCLC (GCL catalytic subunit) that possesses all of the enzymatic activity and a GCLM (GCL modifier subunit) that alters the Ki of GCLC for GSH. We hypothesized that the expression of GCLM and the association of GCLM with GCLC were responsible for the apparent increase in GCL activity state observed in the liver of rats fed low-protein diets or in hepatocytes cultured in low-sulphur amino acid-containing medium. Therefore we conducted a series of studies using rats and a human hepatoma (HepG2/C3A) cell line to assess the role of GCLM and holoenzyme formation in the regulation of GCL activity in response to sulphur amino acid intake or availability. Increases in GCL activity in rat liver, as well as in HepG2 cells, were due to the additive effects of changes in the amount of GCLC and the kcat for GCLC. The increase in the k cat for GCLC was associated with increased holoenzyme formation, which was associated with an increase in the molar ratio of GCLM to GCLC. Furthermore, our results indicate that the GCLM level in rat liver is always limiting and that up-regulation of the GCLM level results in increased holoenzyme formation and an increase in the kcat. This is the first report demonstrating that the catalytic efficiency of rat GCL is increased by holoenzyme formation and the first demonstration of differential up-regulation of the GCL subunits in response to cysteine deprivation.",
keywords = "Cysteine, Glutamate-cysteine ligase (GCL), Glutathione (GSH), HepG2/C3A cells, Holoenzyme, Low-protein diet",
author = "Lee, {Jeong In} and Kang, {Joann J.} and Stipanuk, {Martha H.}",
year = "2006",
month = "1",
day = "1",
doi = "10.1042/BJ20051111",
language = "English (US)",
volume = "393",
pages = "181--190",
journal = "Biochemical Journal",
issn = "0264-6021",
publisher = "Portland Press Ltd.",
number = "1",

}

TY - JOUR

T1 - Differential regulation of glutamate-cysteine ligase subunit expression and increased holoenzyme formation in response to cysteine deprivation

AU - Lee, Jeong In

AU - Kang, Joann J.

AU - Stipanuk, Martha H.

PY - 2006/1/1

Y1 - 2006/1/1

N2 - GCL (glutamate-cysteine ligase) is a heterodimer of a GCLC (GCL catalytic subunit) that possesses all of the enzymatic activity and a GCLM (GCL modifier subunit) that alters the Ki of GCLC for GSH. We hypothesized that the expression of GCLM and the association of GCLM with GCLC were responsible for the apparent increase in GCL activity state observed in the liver of rats fed low-protein diets or in hepatocytes cultured in low-sulphur amino acid-containing medium. Therefore we conducted a series of studies using rats and a human hepatoma (HepG2/C3A) cell line to assess the role of GCLM and holoenzyme formation in the regulation of GCL activity in response to sulphur amino acid intake or availability. Increases in GCL activity in rat liver, as well as in HepG2 cells, were due to the additive effects of changes in the amount of GCLC and the kcat for GCLC. The increase in the k cat for GCLC was associated with increased holoenzyme formation, which was associated with an increase in the molar ratio of GCLM to GCLC. Furthermore, our results indicate that the GCLM level in rat liver is always limiting and that up-regulation of the GCLM level results in increased holoenzyme formation and an increase in the kcat. This is the first report demonstrating that the catalytic efficiency of rat GCL is increased by holoenzyme formation and the first demonstration of differential up-regulation of the GCL subunits in response to cysteine deprivation.

AB - GCL (glutamate-cysteine ligase) is a heterodimer of a GCLC (GCL catalytic subunit) that possesses all of the enzymatic activity and a GCLM (GCL modifier subunit) that alters the Ki of GCLC for GSH. We hypothesized that the expression of GCLM and the association of GCLM with GCLC were responsible for the apparent increase in GCL activity state observed in the liver of rats fed low-protein diets or in hepatocytes cultured in low-sulphur amino acid-containing medium. Therefore we conducted a series of studies using rats and a human hepatoma (HepG2/C3A) cell line to assess the role of GCLM and holoenzyme formation in the regulation of GCL activity in response to sulphur amino acid intake or availability. Increases in GCL activity in rat liver, as well as in HepG2 cells, were due to the additive effects of changes in the amount of GCLC and the kcat for GCLC. The increase in the k cat for GCLC was associated with increased holoenzyme formation, which was associated with an increase in the molar ratio of GCLM to GCLC. Furthermore, our results indicate that the GCLM level in rat liver is always limiting and that up-regulation of the GCLM level results in increased holoenzyme formation and an increase in the kcat. This is the first report demonstrating that the catalytic efficiency of rat GCL is increased by holoenzyme formation and the first demonstration of differential up-regulation of the GCL subunits in response to cysteine deprivation.

KW - Cysteine

KW - Glutamate-cysteine ligase (GCL)

KW - Glutathione (GSH)

KW - HepG2/C3A cells

KW - Holoenzyme

KW - Low-protein diet

UR - http://www.scopus.com/inward/record.url?scp=30044452581&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=30044452581&partnerID=8YFLogxK

U2 - 10.1042/BJ20051111

DO - 10.1042/BJ20051111

M3 - Article

C2 - 16137247

AN - SCOPUS:30044452581

VL - 393

SP - 181

EP - 190

JO - Biochemical Journal

JF - Biochemical Journal

SN - 0264-6021

IS - 1

ER -